Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
3.870
+0.010 (0.26%)
At close: Aug 3, 2026, 4:00 PM EDT
3.875
+0.005 (0.13%)
After-hours: Aug 3, 2026, 7:34 PM EDT
Bicycle Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Bicycle Therapeutics stock has a consensus rating of "Buy" and an average price target of $9.86. The average 1-year stock price forecast is 154.78% higher than the current stock price, while the lowest is $5.00 (+29.20%) and the highest is $14 (+261.76%).
Price Target: $9.86 (+154.78%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Bicycle Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 5 | 5 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 11 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $36 → $11 | Buy | Maintains | $36 → $11 | +184.24% | Jul 31, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $7 | Hold | Maintains | $7 | +80.88% | Jul 31, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 31, 2026 |
| Needham | Needham | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +261.76% | Jul 30, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $5 | Hold | Maintains | $5 | +29.20% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
16.31M
from 72.59M
Decreased by -77.53%
Revenue Next Year
6.69M
from 16.31M
Decreased by -59.00%
EPS This Year
-2.61
from -3.16
EPS Next Year
-2.22
from -2.61
EPS and Forward PE are based on non-GAAP adjusted numbers.